MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-13-2026
Exact Sciences Corporation EBITDA per Share 2011-2026 | EXAS
Annual EBITDA per Share Exact Sciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.43 | -5.04 | -0.56 | -2.8 | -4.44 | -4.62 | -1.66 | -1.12 | -0.888 | -1.54 | -1.68 | -1.23 | -0.671 | -0.869 | -0.541 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.43 | -5.04 | -1.87 |
Quarterly EBITDA per Share Exact Sciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.03 | 0.15 | -0.35 | - | -0.05 | 0.02 | -0.42 | - | 0.2 | -0.27 | -0.28 | - | -0.64 | -0.76 | -0.88 | - | -0.81 | -0.88 | -1.65 | - | -1 | -0.22 | -0.45 | -0.59 | -0.11 | -0.16 | -0.49 | -0.4 | -0.22 | -0.2 | -0.27 | -0.19 | -0.23 | -0.28 | -0.32 | -0.35 | -0.36 | -0.46 | -0.47 | -0.42 | -0.46 | -0.44 | -0.39 | -0.38 | -0.36 | -0.22 | -0.22 | -0.17 | -0.15 | -0.18 | -0.17 | -0.22 | -0.2 | -0.25 | -0.19 | -0.19 | -0.14 | -0.12 | -0.08 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.2 | -1.65 | -0.339 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
5.49 | $ 117.49 | 2.11 % | $ 35.7 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 133.59 | -0.5 % | $ 6.25 B | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 8.81 | -3.29 % | $ 11.7 M | USA |
 |
Castle Biosciences
CSTL
|
-0.07 | $ 20.18 | 2.49 % | $ 585 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-1.46 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Fulgent Genetics
FLGT
|
-2.18 | $ 17.68 | 0.03 % | $ 544 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
-3.17 | $ 121.14 | 1.08 % | $ 15.2 B | USA |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 21.65 | 0.51 % | $ 1.15 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.38 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 114.27 | 0.37 % | $ 9.43 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 1.8 | -1.1 % | $ 7.96 M | USA |
 |
Illumina
ILMN
|
-3.01 | $ 145.45 | 0.15 % | $ 23.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M |  China |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 98.62 | -1.44 % | $ 6.66 B | USA |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 161.57 | 3.21 % | $ 8.01 B | USA |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 115.21 | 1.26 % | $ 23 B |  Schweiz |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 9.31 | 0.43 % | $ 1.19 B | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 427.31 | -0.42 % | $ 12.3 B | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 18.94 | -0.53 % | $ 424 M | USA |
 |
Natera
NTRA
|
-5.33 | $ 199.2 | -0.85 % | $ 19.6 B | USA |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 3.87 | 0.52 % | $ 358 M | USA |
 |
Personalis
PSNL
|
-0.87 | $ 9.01 | 0.73 % | $ 804 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.69 | $ 26.87 | -0.32 % | $ 25.5 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 6.38 | -0.85 % | $ 266 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
0.22 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.47 | - | $ 5.67 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-1.86 | $ 66.0 | 1.74 % | $ 3.95 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 263.33 | 1.9 % | $ 21.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
23.3 | $ 455.11 | 1.53 % | $ 172 B | USA |
 |
Waters Corporation
WAT
|
6.02 | $ 345.15 | 1.91 % | $ 20.6 B | USA |
 |
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.64 | -1.87 % | $ 230 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.29 | 1.59 % | $ 2.01 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 195.77 | 1.48 % | $ 21.7 B | USA |